Combining vasculature disrupting agent and Toll-like receptor 7/8 agonist for cancer therapy.
about
Co-delivery of Dual Toll-Like Receptor Agonists and Antigen in Poly(Lactic-Co-Glycolic) Acid/Polyethylenimine Cationic Hybrid Nanoparticles Promote Efficient In Vivo Immune Responses.Combination therapy of simvastatin and 5, 6-dimethylxanthenone-4-acetic acid synergistically suppresses the aggressiveness of B16.F10 melanoma cells
P2860
Combining vasculature disrupting agent and Toll-like receptor 7/8 agonist for cancer therapy.
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Combining vasculature disrupti ...... /8 agonist for cancer therapy.
@ast
Combining vasculature disrupti ...... /8 agonist for cancer therapy.
@en
type
label
Combining vasculature disrupti ...... /8 agonist for cancer therapy.
@ast
Combining vasculature disrupti ...... /8 agonist for cancer therapy.
@en
prefLabel
Combining vasculature disrupti ...... /8 agonist for cancer therapy.
@ast
Combining vasculature disrupti ...... /8 agonist for cancer therapy.
@en
P2093
P2860
P356
P1433
P1476
Combining vasculature disrupti ...... 7/8 agonist for cancer therapy
@en
P2093
Cheongsoo Park
Hyunseung Lee
Inpyo Choi
Joo-Yong Lee
Kwan Soo Hong
Mi Young Cho
Yong Taik Lim
P2860
P304
P356
10.18632/ONCOTARGET.14260
P407
P577
2017-01-01T00:00:00Z